NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 15,140,525
- Share change
- +2,946,046
- Total reported value
- $25,329,475
- Put/Call ratio
- 63%
- Price per share
- $1.67
- Number of holders
- 37
- Value change
- +$4,917,141
- Number of buys
- 8
- Number of sells
- 21
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.6%
|
6,909,220
|
$12,851,149 | — | 31 Mar 2024 | |
| Caligan Partners LP |
13F
|
Company |
0.29%
|
756,538
|
$1,407,161 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.23%
|
617,100
|
$1,147,806 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
575,580
|
$1,070,579 | — | 31 Mar 2024 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.21%
|
566,650
|
$1,053,969 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.16%
|
432,621
|
$805,000 | — | 31 Mar 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
378,269
|
$703,580 | — | 31 Mar 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.12%
|
325,762
|
$605,917 | — | 31 Mar 2024 | |
| EDBI Pte Ltd |
13F
|
Company |
0.08%
|
222,136
|
$413,173 | — | 31 Mar 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.06%
|
162,580
|
$302,399 | — | 31 Mar 2024 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0.06%
|
146,290
|
$272,099 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.05%
|
134,977
|
$251,057 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
110,373
|
$205,294 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
93,508
|
$173,925 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.03%
|
85,144
|
$158,368 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
84,941
|
$157,990 | — | 31 Mar 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
81,262
|
$151,147 | — | 31 Mar 2024 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.03%
|
74,723
|
$138,985 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.03%
|
71,088
|
$132,222 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
63,800
|
$119,000 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
60,407
|
$112,357 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
38,552
|
$71,707 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
34,347
|
$63,885 | — | 31 Mar 2024 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
31,535
|
$58,655 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.01%
|
30,485
|
$56,702 | — | 31 Mar 2024 | |
| Donald L. Hagan, LLC |
13F
|
Company |
0.01%
|
30,000
|
$55,800 | — | 31 Mar 2024 | |
| Atom Investors LP |
13F
|
Company |
0.01%
|
29,612
|
$55,078 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
18,857
|
$35,074 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
10,109
|
$18,803 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
7,923
|
$14,736 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
4,065
|
$7,561 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,644
|
$3,000 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
1,371
|
$2,549 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,331
|
$2,476 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,191
|
$2,216 | — | 31 Mar 2024 | |
| Frazier Financial Advisors, LLC |
13F
|
Company |
0%
|
375
|
$698 | — | 31 Mar 2024 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
63
|
$117 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
50
|
$93 | — | 31 Mar 2024 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q2 2024
As of 30 Jun 2024,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,140,525 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., Caligan Partners LP, BOOTHBAY FUND MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, Temasek Holdings (Private) Ltd, TWO SIGMA INVESTMENTS, LP, GSA CAPITAL PARTNERS LLP, Exome Asset Management LLC, BANK OF MONTREAL /CAN/, and EDBI Pte Ltd.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
38
Q2 2024 holders
37
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.